Ertugliflozin (Steglatro)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Ertugliflozin (Steglatro), covering 2019-02-18 to 2025-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Ertugliflozin to Reduce Arrhythmic Burden in ICD/CRT patientS (ERASe-Trial) - a Phase III Study [Phase 3]